World Of Taxonomy
65597-407Level 3

Turalio (pexidartinib hydrochloride)

**Product type:** Human Prescription Drug

**Active ingredient:** PEXIDARTINIB HYDROCHLORIDE

**Strength:** 125 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Daiichi Sankyo Inc.

**Marketing category:** NDA (NDA211810)

**Pharmacologic class:** Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA], UGT1A1 Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/65597-407
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.